Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference

      Share Article
      share to

      New Brunswick, NJ (February 7th, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7th. Mathai Mammen, Executive Vice President, Pharmaceuticals R&D will represent the Company in a session scheduled at 9:10 a.m. (Eastern Time).

      This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

      A webcast and podcast replay will be available approximately 48 hours after the live webcast.

      Press Contacts:
      Linda Fedow
      (732) 524-6071

      Investor Contacts:
      Raychel Kruper
      (732) 524-6164

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.